Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Primary Tumor Burden Score: A Novel Staging Parameter Superior to ypT-category for Esophageal Squamous Cell Carcinoma After Neoadjuvant Chemoradiotherapy

NCT05839002 is registered in ClinicalTrials.gov with Fudan University as lead sponsor.

NCT NCT05839002
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05839002 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Primary Tumor Burden Score: A Novel Staging Parameter Superior to ypT-category for Esophageal Squamous Cell Carcinoma After Neoadjuvant Chemoradiotherapy
Lead sponsor
Fudan University
Phase
Observational
Overall status
Completed
Start date
May 21, 2010
Completion date
March 15, 2023
Enrollment
187 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

neoplasm, esophagus, neoplasm, squamous cell